Abstract
PROGRESSION (Two of the following) Increase of more than 20% in sum LD of target lesions Solid mass, invasion adjacent structures Higher SUV or larger area of FDG uptake A. Pennathur1, B. W. Loo2, D. E. Heron1,R. I. Whyte3, A. Zajac4, D. G. Brachman5, W. E. Gooding1, N. A. Christie1, H. D. Urschel6 J. D. Luketich1* 1University of Pittsburgh Medical Center, Pittsburgh, PA, 2Stanford University School of Medicine, Stanford, CA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4St.Catherine Hospital, East Chicago, IN, 5Arizona Oncology Services Foundation, Phoenix, AZ, 6Baylor Medical Center, Dallas, TX
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
